Resources

Hear from Richard Kennedy as he explores how Simtra’s expanding capacity and capabilities are designed to give our customers greater flexibility, technical expertise, and manufacturing support as their program evolves.

Simtra’s most recent expansion in Halle/Westfalen, Germany, offers new state-of-the-art equipment, trusted expertise and reliable, flexible capacity for manufacturing prefilled syringes.

When particulates are observed during sterile injectable manufacturing or in filled product, rapid isolation and identification can help determine their potential source and support timely resolution. Learn how Simtra’s onsite team works to provide particle identification data within 24 hours.

Discover how Simtra’s dual approach to formulation development uses early stability data to inform whether a drug is best suited for a solution or lyophilized presentation, while establishing a foundation for process development.

Simtra is increasing its capabilities for standard- and high-potency sterile injectable manufacturing, offering customizable production solutions and commercial-scale OEB 5 fill/finish operations.

Simtra is expanding its prefilled syringe and vial manufacturing capacity to support highly reliable, scalable operations from development through commercial production.

During this webinar, learn more about Simtra’s recent investments across our manufacturing network and the capabilities supporting the next generation of injectable therapies.

As demonstrated in this case study, Simtra applies deep expertise in lyophilization optimization to overcome the two major challenges inherent in lyophilizing ADCs: phase separation during freezing and destabilization during drying.

Yuliana Mendez presents an update of the ongoing capability expansions for Building H located at our Bloomington, Indiana campus.